Home/Filings/4/0001179110-04-020146
4//SEC Filing

WEBB MICHAEL D 4

Accession 0001179110-04-020146

CIK 0001027702other

Filed

Oct 25, 8:00 PM ET

Accepted

Oct 26, 8:37 PM ET

Size

12.9 KB

Accession

0001179110-04-020146

Insider Transaction Report

Form 4
Period: 2004-10-22
WEBB MICHAEL D
DirectorChief Executive Officer
Transactions
  • Sale

    Common Stock (Sale Pursuant to a 10b5-1 Trading Plan)

    2004-10-22$16.70/sh700$11,69039,012 total
  • Exercise/Conversion

    Common Stock

    2004-10-22$0.45/sh+5,000$2,27043,912 total
  • Sale

    Common Stock (Sale Pursuant to a 10b5-1 Trading Plan)

    2004-10-22$16.50/sh2,500$41,25041,412 total
  • Sale

    Common Stock (Sale Pursuant to a 10b5-1 Trading Plan)

    2004-10-22$16.75/sh100$1,67538,912 total
  • Sale

    Common Stock (Sale Pursuant to a 10b5-1 Trading Plan)

    2004-10-22$16.65/sh1,700$28,30539,712 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2004-10-22$0.45/sh+5,000$2,270
    Exercise: $0.45From: 1999-12-16Exp: 2004-12-16Common Stock (5,000 underlying)
Footnotes (2)
  • [F1]Reporting person indirectly owns 2,500 shares of common stock through his spouse.
  • [F2]From December 16, 1994 grant of 330,467 options to purchase shares of common stock of which 302,326 options have been exercised and the remaining 32,461 options are currently exercisable.

Issuer

EPIX Pharmaceuticals, Inc.

CIK 0001027702

Entity typeother

Related Parties

1
  • filerCIK 0001239463

Filing Metadata

Form type
4
Filed
Oct 25, 8:00 PM ET
Accepted
Oct 26, 8:37 PM ET
Size
12.9 KB